{"id":"W3125989326","doi":"10.1101/2021.01.26.428337","title":"STING agonism enhances anti-tumor immune responses and therapeutic efficacy of PARP inhibition in <i>BRCA</i> -associated breast cancer","year":2021,"lang":"en","type":"preprint","venue":"bioRxiv (Cold Spring Harbor Laboratory)","topic":"interferon and immune responses","field":"Immunology and Microbiology","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Daiichi Sankyo Europe; Dana-Farber/Harvard Cancer Center; Ludwig Center at Harvard; National Institutes of Health; Sierra Oncology; Ipsen; Astex Pharmaceuticals; G1 Therapeutics; Pfizer; Merck KGaA; Array BioPharma; Eli Lilly and Company","keywords":"Cancer research; Immune system; Breast cancer; Stimulator of interferon genes; Cancer; PARP inhibitor; Proinflammatory cytokine; Poly ADP ribose polymerase; Medicine; Sting; Immunology; Dendritic cell; Immunotherapy; T cell; Pharmacology; Biology; Internal medicine; Innate immune system; Inflammation; Polymerase","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009247892,0.0005496225,0.001075293,0.0003968981,0.0001807223,0.00009720323,0.0002639609,0.0006705301,0.0001856942],"category_scores_gemma":[0.0004109965,0.0005623568,0.0001843648,0.0004415732,0.0004245829,0.0001219283,0.0004651113,0.001058635,0.00001311302],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002191339,"about_ca_system_score_gemma":0.0008325005,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006201204,"about_ca_topic_score_gemma":0.0000226574,"domain_scores_codex":[0.9964188,0.001093985,0.0009420326,0.0008183566,0.0001035271,0.0006233496],"domain_scores_gemma":[0.9976855,0.0004196362,0.0007857965,0.000637856,0.0004286443,0.00004258816],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0006818043,0.0004027994,0.00639948,0.0002182848,0.0004200171,0.00005296685,0.0001000211,0.00001072022,0.9916391,0.00004398888,0.00001345424,0.00001735694],"study_design_scores_gemma":[0.001148841,0.00005814269,0.402197,0.001505237,0.00008356948,3.621841e-7,0.00003158688,0.000006893626,0.594532,3.538791e-7,0.00009192429,0.0003441173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9572371,0.04048989,0.00002391477,0.0001926269,0.001067321,0.0004842936,0.0003756516,0.0001259726,0.000003177278],"genre_scores_gemma":[0.9974741,0.002041619,0.0000430356,0.0001862953,0.0000432657,0.0001136796,0.000002682755,0.00007775686,0.0000175733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3971071,"threshold_uncertainty_score":0.9996828,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01231609409758963,"score_gpt":0.2376792740582465,"score_spread":0.2253631799606568,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}